目的:探讨子宫肌瘤大小对妊娠结局的影响.方法:选取2014年至2017年之间在我院分娩的孕妇经超声检查为合并子宫肌瘤的患者230例作为观察组,其中肌瘤直径超过5cm的患者120例,肌瘤直径小于5cm的患者110例,同时选择同时期在我院行剖宫产的无子宫肌瘤的孕妇119例作为对照组,对三者的孕期及分娩时并发症:先兆流产、先兆早产、胎位异常、宫缩乏力、胎盘早剥、分娩出血进行比较.结果:肌瘤直径大于5 cm组孕期及分娩时并发症要高于对照组及肌瘤直径小于5 cm组,而肌瘤直径小于5 cm组与对照组比较并发症无明显差别.结论:对于妊娠合并肌瘤直径超过5 cm的患者应密切观察,并及时处理.

目的 探究宫颈扩张球囊与地诺前列酮用于足月妊娠促宫颈成熟的效果.方法 运用随机数表分组法选取我院妇产科收治的具有引产指征的产妇109例,为促宫颈成熟将其分组为地诺前列酮组(n=54例)和宫颈扩张球囊组(n=55例),并对两组产妇促宫颈成熟后出现的不良反应发生情况进行对比.结果 宫颈扩张球囊组促宫颈成熟后不良反应发生率3.64％显著低于地诺前列酮组促宫颈成熟后不良反应发生率14.81％(P<0.05).结论 对产妇使用宫颈扩张球囊进行促宫颈成熟的工作,有利于帮助产妇减少受到不良反应的影响,临床效果显著.

目的 :评价鳞状细胞癌抗原(SCCA)、细胞角蛋白19片段(CYFRA21-1)、糖类抗原125(CA125)联合检测对发现早期宫颈癌的临床价值.方法:选取100例经临床病理诊断为宫颈癌的妇女作为观察组,并选取80例同时期正常体检的妇女作为对照组,检测两组血清的SCCA、CYFRA21-1、CA125水平.结果:宫颈癌患者血清中的SCCA、CYFRA21-1、CA125均高于正常体检者,差异有统计学意义(P<0.05).且三者联合检测可提高对早期宫颈癌患者筛查的灵敏度.结论:血清SCCA、CYFRA21-1、CA125可以作为宫颈癌辅助诊断的有效指标,三者联合检测更加有助于女性宫颈癌早期诊断.

目的 探究地诺前列酮与双球囊导管用于促宫颈成熟的疗效及安全性.方法 选取2018年8月～2019年2月我院妇产科收治的具有引产指征的产妇87例作为研究对象,通过随机分组法将其分为地诺前列酮组43例和双球囊导管组44例,并对两组产妇促宫颈成熟的效果进行对比.结果 双球囊导管组促宫颈成熟后宫颈Bishop评分(8.58±2.21)分显著高于地诺前列酮组促宫颈成熟后宫颈Bishop评分(6.49±1.87)分,差异有统计学意义(P<0.05).结论 对产妇使用双球囊导管进行促宫颈成熟的工作,对于产妇宫颈成熟效果的提升有着积极的促进作用,效果显著.

目的:探究口服米非司酮联合甲氨蝶呤妊娠囊内注射治疗子宫瘢痕妊娠的临床效果.方法:选取我院收治的子宫瘢痕妊娠妇女62例,随机分为对照组31例,给予甲氨蝶呤妊娠囊内注射;观察组31例,在对照组的基础上采用米非司酮口服联合治疗.观察两组临床治疗效果.结果:观察组临床表现缓解时间明显较对照组短(P＜0.05),观察组治疗后血β-HCG显著低于对照组(P＜0.05),观察组不良反应发生率明显较对照组低,且P＜0.05,两组数据差异具有统计学意叉.结论:米非司酮口服联合甲氨蝶呤妊娠囊内注射治疗子宫瘢痕妊娠相对于诞辰采用甲氨蝶呤妊娠囊内注射治疗效果显著,可有效降低患者血人绒毛膜促性腺激素,缓解子宫瘢痕,且具有较高安全性,值得临床运用推广.

Objective:To investigate the clinical effect of modified Sini San combined with acupuncture in the treatment of liver-stomach disharmony.Methods:97 cases of pregnant vomiting patients with the pattern of liver-stomach disharmony were randomly divided into the observation group (49 cases) and the control group (48 cases).The observation group was treated with modified Sini San combined with acupuncture, and the control group was treated with Sini San alone.The clinical efficacy after medication, the TCM syndrome integral, and serum levels of β-HCG before and after medication were compared between the two groups.Results:The clinical effective rate of the observation group was 97.96%, which was higher than 83.33% of the control group, the difference was significant(P<0.05).There was no significant differences in terms of β-HCG level and TCM syndrome integral betwe the two groups before medication(P>0.05);after medication, the TCM syndrome integral and serum β-HCG levels of the observation group {(7.21± 0.84), (210 168±9 420.25)Mlu/ml} improved more than those in the control group {(13.15±0.67), (201 535±9 625.06) Mlu/ml}, in which there was a statistical significance(P<0.05).Conclusion:The modified Sini San combined with acupuncture has a good clinical effect for pregnant vomiting with liver-stomach disharmony, it can obviously improve the symptoms of pregnant women without toxic reaction or side effect for mother and fetus;therefore, it is worthy of clinical application.

Objective: To observe the clinical effect of Xiaobanxia Jupi Zhuru Decoction in treating pregnancy evil.Methods: 100 patients of pregnancy evil were selected from Jun 2013 to Jan 2015,according to the principle of randomization,patients were divided into control group (western medicine routine treatment) and observation group (western medicine routine treatment jointed Xiaobanxia Jupi Zhuru Decoction),while 50 cases in each group.The clinical therapeutic effect of two groups were compared.Results: The total efficiency of the observation group was higher than the control group,the difference was statistically significant (P<0.05).Conclusion: The treatment of pregnancy evil by the combination of Xiaobanxia Jupi Zhuru Decoction can significantly improve the therapeutic effect, shorten the course of disease and reduce the recurrence rate,and can significantly promote the embryo development.